PharmaBlock Sciences Nanjing Inc
SZSE:300725

Watchlist Manager
PharmaBlock Sciences Nanjing Inc Logo
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Watchlist
Price: 35.4 CNY 0.97% Market Closed
Market Cap: 7B CNY
Have any thoughts about
PharmaBlock Sciences Nanjing Inc?
Write Note

Intrinsic Value

The intrinsic value of one PharmaBlock Sciences Nanjing Inc stock under the Base Case scenario is 54.29 CNY. Compared to the current market price of 35.4 CNY, PharmaBlock Sciences Nanjing Inc is Undervalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
54.29 CNY
Undervaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
PharmaBlock Sciences Nanjing Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PharmaBlock Sciences Nanjing Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PharmaBlock Sciences Nanjing Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about PharmaBlock Sciences Nanjing Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

35.4 CNY
+0.97%
+0.97%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

PharmaBlock Sciences Nanjing Inc
CN
Pharmaceuticals
Market Cap
7B CNY
IPO
Nov 10, 2017
Employees
1 735
China
Market Cap
7B CNY
Industry
Pharmaceuticals
IPO
Nov 10, 2017
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about PharmaBlock Sciences Nanjing Inc

Provide an overview of the primary business activities
of PharmaBlock Sciences Nanjing Inc.

What unique competitive advantages
does PharmaBlock Sciences Nanjing Inc hold over its rivals?

What risks and challenges
does PharmaBlock Sciences Nanjing Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PharmaBlock Sciences Nanjing Inc.

Provide P/S
for PharmaBlock Sciences Nanjing Inc.

Provide P/E
for PharmaBlock Sciences Nanjing Inc.

Provide P/OCF
for PharmaBlock Sciences Nanjing Inc.

Provide P/FCFE
for PharmaBlock Sciences Nanjing Inc.

Provide P/B
for PharmaBlock Sciences Nanjing Inc.

Provide EV/S
for PharmaBlock Sciences Nanjing Inc.

Provide EV/GP
for PharmaBlock Sciences Nanjing Inc.

Provide EV/EBITDA
for PharmaBlock Sciences Nanjing Inc.

Provide EV/EBIT
for PharmaBlock Sciences Nanjing Inc.

Provide EV/OCF
for PharmaBlock Sciences Nanjing Inc.

Provide EV/FCFF
for PharmaBlock Sciences Nanjing Inc.

Provide EV/IC
for PharmaBlock Sciences Nanjing Inc.

Show me price targets
for PharmaBlock Sciences Nanjing Inc made by professional analysts.

What are the Revenue projections
for PharmaBlock Sciences Nanjing Inc?

How accurate were the past Revenue estimates
for PharmaBlock Sciences Nanjing Inc?

What are the Net Income projections
for PharmaBlock Sciences Nanjing Inc?

How accurate were the past Net Income estimates
for PharmaBlock Sciences Nanjing Inc?

What are the EPS projections
for PharmaBlock Sciences Nanjing Inc?

How accurate were the past EPS estimates
for PharmaBlock Sciences Nanjing Inc?

What are the EBIT projections
for PharmaBlock Sciences Nanjing Inc?

How accurate were the past EBIT estimates
for PharmaBlock Sciences Nanjing Inc?

Compare the revenue forecasts
for PharmaBlock Sciences Nanjing Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PharmaBlock Sciences Nanjing Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PharmaBlock Sciences Nanjing Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of PharmaBlock Sciences Nanjing Inc compared to its peers.

Compare the P/E ratios
of PharmaBlock Sciences Nanjing Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing PharmaBlock Sciences Nanjing Inc with its peers.

Analyze the financial leverage
of PharmaBlock Sciences Nanjing Inc compared to its main competitors.

Show all profitability ratios
for PharmaBlock Sciences Nanjing Inc.

Provide ROE
for PharmaBlock Sciences Nanjing Inc.

Provide ROA
for PharmaBlock Sciences Nanjing Inc.

Provide ROIC
for PharmaBlock Sciences Nanjing Inc.

Provide ROCE
for PharmaBlock Sciences Nanjing Inc.

Provide Gross Margin
for PharmaBlock Sciences Nanjing Inc.

Provide Operating Margin
for PharmaBlock Sciences Nanjing Inc.

Provide Net Margin
for PharmaBlock Sciences Nanjing Inc.

Provide FCF Margin
for PharmaBlock Sciences Nanjing Inc.

Show all solvency ratios
for PharmaBlock Sciences Nanjing Inc.

Provide D/E Ratio
for PharmaBlock Sciences Nanjing Inc.

Provide D/A Ratio
for PharmaBlock Sciences Nanjing Inc.

Provide Interest Coverage Ratio
for PharmaBlock Sciences Nanjing Inc.

Provide Altman Z-Score Ratio
for PharmaBlock Sciences Nanjing Inc.

Provide Quick Ratio
for PharmaBlock Sciences Nanjing Inc.

Provide Current Ratio
for PharmaBlock Sciences Nanjing Inc.

Provide Cash Ratio
for PharmaBlock Sciences Nanjing Inc.

What is the historical Revenue growth
over the last 5 years for PharmaBlock Sciences Nanjing Inc?

What is the historical Net Income growth
over the last 5 years for PharmaBlock Sciences Nanjing Inc?

What is the current Free Cash Flow
of PharmaBlock Sciences Nanjing Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for PharmaBlock Sciences Nanjing Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PharmaBlock Sciences Nanjing Inc

Current Assets 2.5B
Cash & Short-Term Investments 1.2B
Receivables 406.1m
Other Current Assets 831.8m
Non-Current Assets 2.3B
Long-Term Investments 5.4m
PP&E 1.7B
Intangibles 463.9m
Other Non-Current Assets 59.3m
Current Liabilities 609.7m
Accounts Payable 220.7m
Accrued Liabilities 73.5m
Short-Term Debt 55.3m
Other Current Liabilities 260.2m
Non-Current Liabilities 1.2B
Long-Term Debt 1.2B
Other Non-Current Liabilities 71.8m
Efficiency

Earnings Waterfall
PharmaBlock Sciences Nanjing Inc

Revenue
1.6B CNY
Cost of Revenue
-960.2m CNY
Gross Profit
601.5m CNY
Operating Expenses
-407.5m CNY
Operating Income
194m CNY
Other Expenses
-18.9m CNY
Net Income
175.1m CNY

Free Cash Flow Analysis
PharmaBlock Sciences Nanjing Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

PharmaBlock Sciences Nanjing Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Net Income
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
48/100
Profitability
Score

PharmaBlock Sciences Nanjing Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

PharmaBlock Sciences Nanjing Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Low D/E
Long-Term Solvency
69/100
Solvency
Score

PharmaBlock Sciences Nanjing Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
PharmaBlock Sciences Nanjing Inc

Wall Street analysts forecast PharmaBlock Sciences Nanjing Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaBlock Sciences Nanjing Inc is 40.8 CNY with a low forecast of 40.4 CNY and a high forecast of 42 CNY.

Lowest
Price Target
40.4 CNY
14% Upside
Average
Price Target
40.8 CNY
15% Upside
Highest
Price Target
42 CNY
19% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PharmaBlock Sciences Nanjing Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PharmaBlock Sciences Nanjing Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one PharmaBlock Sciences Nanjing Inc stock?

The intrinsic value of one PharmaBlock Sciences Nanjing Inc stock under the Base Case scenario is 54.29 CNY.

Is PharmaBlock Sciences Nanjing Inc stock undervalued or overvalued?

Compared to the current market price of 35.4 CNY, PharmaBlock Sciences Nanjing Inc is Undervalued by 35%.

Back to Top